Lecture
to ASIA (American Spinal Injury Association), Denver,
14-16/05/2004
Activated Autologous Macrophages
Therapy for Spinal Cord Injury: characterization of the
cellular phenotype
Ina Sarel, Shahar Ish-Shalom, Ronit
Bakimer, Orly Aziz, Eilat Bain, Michal Schrift-Tzadok,
Marina Bubis, Yona Geffen, Jonathan B. Marder, Ziv Shulman
and Eti Yoles
Proneuron Biotechnologies, Ness Ziona, Israel
Objective: Complete spinal cord
injury leads to irreversible motor and sensory functional
loss. The immune system is the body's machinery for wound
healing and repair. However, the central nervous system's
wound-healing response is less effective because of its
"immune- privileged" character. Spinal cord injured rats,
implanted with macrophages that were previously co-incubated
with sciatic nerve or skin, show significantly improved
functional recovery. Based on the encouraging preclinical
animal results, we are conducting a phase II clinical trial
of a cell therapy for patients with acute spinal cord
injury. Here we report on characterization of the
therapeutic macrophages.
Design: Monocytes isolated from
peripheral blood of human donors were stimulated by
co-incubation with skin tissue, producing a distinct
cellular phenotype associated with wound healing.
Methods: The incubated cells
were analyzed for morphological characteristics, the
expression of membrane markers and cytokine secretion.
Results: Skin co-incubation
caused significant increase in granule number and size, and
changes in granule contents. Skin-coincubated macrophages
expressed higher levels of the costimulatory molecules CD80
and CD86, and of adhesion molecule ICAM1 (CD54), reminiscent
of antigen presenting cells. Additionally, co-incubation
with skin resulted in increased secretion of the
proinflammatory cytokine interleukin 1-beta and of
Brain-Derived Neurotrophic Factor.
Conclusions: The above features
of skin-coincubated macrophages suggest possible mechanisms
by which they may support an immune response that promotes
neuronal cell survival and repair.